## Background: Clinical outcomes vary for patients treated with radical cystectomy. the authors sought to identify factors associated with the survival of patients treated with radical cystectomy for urothelial carcinoma of the urinary bladder. ## Methods: The authors studied 218 patients treated
A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer
✍ Scribed by Giovanni Lughezzani; Maxine Sun; Shahrokh F. Shariat; Lars Budäus; Rodolphe Thuret; Claudio Jeldres; Daniel Liberman; Francesco Montorsi; Paul Perrotte; Pierre I. Karakiewicz
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 247 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Platinum‐based adjuvant chemotherapy in randomized trials has failed to provide a survival benefit in patients with resected stage I nonsmall cell lung cancer (NSCLC). Using data from the California Cancer Registry (CCR), we explored factors that had detrimental effects
## Abstract ## BACKGROUND: Sunitinib has replaced interferon (IFN) as a first‐line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. ## METH
## Abstract Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disorder that predisposes to predominantly colorectal and endometrial cancers due to germline mutations in DNA mismatch repair genes, mainly __MLH1__, __MSH2__ and in families with excess endometrial cancer also